au.\*:("TAMMINGA C")
Results 1 to 25 of 85
Selection :
EFFECT OF APOMORPHINE ON SCHIZOPHRENIC SYMPTOMS.SMITH RC; TAMMINGA C; DAVIS JM et al.1977; J. NEUR. TRANSM.; AUSTR.; DA. 1977; VOL. 40; NO 2; PP. 171-176; BIBL. 16 REF.Article
Partial dopamine agonists in the treatment of psychosisTAMMINGA, C. A.Journal of neural transmission. 2002, Vol 109, Num 3, pp 411-420, issn 0300-9564Article
NEUROSCIENCE AND SCHIZOPHRENIATAMMINGA, C. A.Biological psychiatry (1969). 1999, Vol 46, Num 3, pp 301-302, issn 0006-3223, 2 p.Conference Paper
Basal ganglia GABAA and dopamine D1 binding site correlates of haloperidol-induced oral dyskinesias in ratSHIRAKAWA, O; TAMMINGA, C. A.Experimental neurology (Print). 1994, Vol 127, Num 1, pp 62-69, issn 0014-4886Article
POTSYNAPTIC SUPERSENSITIVITY IN SCHIZOPHRENIA.PANDEY GN; GARVER DL; TAMMINGA C et al.1977; AMER. J. PSYCHIATRY; U.S.A.; DA. 1977; VOL. 134; NO 5; PP. 518-522; BIBL. 24 REF.Article
GLUTAMATERGIC ASPECTS OF SCHIZOPHRENIATAMMINGA, C.British journal of psychiatry. Supplement. 1999, Vol 174, Num 37, pp 12-15, issn 0960-5371, 4 p.Conference Paper
The endocrinology of extrapyramidal system disordersKIRKPATRICK, B; TAMMINGA, C. A.Endocrinology and metabolism clinics of North America. 1988, Vol 17, Num 1, pp 159-172, issn 0889-8529Article
MK801 induces late regional increases in NMDA and kainate receptor binding in rat brainGAO, X.-M; TAMMINGA, C. A.Journal of neural transmission. 1995, Vol 101, Num 1-3, pp 105-113, issn 0300-9564Article
Chronic olanzapine or sertindole treatment results in reduced oral chewing movements in rats compared to haloperidolGAO, X.-M; SAKAI, K; TAMMINGA, C. A et al.Neuropsychopharmacology (New York, NY). 1998, Vol 19, Num 5, pp 428-433, issn 0893-133XArticle
The application of neuroimaging techniques to drug developmentTAMMINGA, C. A; CONLEY, R. R.The Journal of clinical psychiatry. 1997, Vol 58, pp 3-6, issn 0160-6689, SUP10Conference Paper
Low dose raclopride spares the extrapyramidal system in rat brain from metabolic effectsTARAZI, F. I; SHIRAKAWA, O; TAMMINGA, C. A et al.European journal of pharmacology. 1993, Vol 232, Num 1, pp 71-77, issn 0014-2999Article
Effects of systemically administered cholecystokinin-octapeptide on local cerebral metabolismLUCIGNANI, G; PORRINO, L. J; TAMMINGA, C. A et al.European journal of pharmacology. 1984, Vol 101, Num 1-2, pp 147-151, issn 0014-2999Article
Gender and schizophreniaTAMMINGA, C. A.The Journal of clinical psychiatry. 1997, Vol 58, pp 33-37, issn 0160-6689, SUP15Article
Why neuroleptic withdrawal in schizophrenia ?CARPENTER, W. T; TAMMINGA, C. A.Archives of general psychiatry. 1995, Vol 52, Num 3, pp 192-193, issn 0003-990XArticle
Phenotype of schizophrenia: a review and formulationTAMMINGA, C. A; HOLCOMB, H. H.Molecular psychiatry. 2005, Vol 10, Num 1, pp 27-39, issn 1359-4184, 13 p.Article
International Congress on Schizophrenia ResearchNUSBAUM, S; SCHULZ, C; TAMMINGA, C et al.Schizophrenia research. 1997, Vol 24, Num 1-2, issn 0920-9964, 288 p.Conference Proceedings
Human brain receptors. III: Molecular model : G protein-coupled receptorsTAMMINGA, C. A; DAHL, S. G.The American journal of psychiatry. 1994, Vol 151, Num 4, issn 0002-953X, p. 499Article
An increase in NMDA-sensitive [3H]glutamate and [3H]kainate binding in hippocampus 24 hours after PCPXUE-MIN GAO; TAMMINGA, C. A.Neuroscience letters. 1994, Vol 174, Num 2, pp 149-153, issn 0304-3940Article
Increased growth hormone response to clonidine in 6-hydroxydopamine-treated ratsSIEVER, L. J; TAMMINGA, C; PERT, A et al.Psychopharmacologia. 1987, Vol 91, Num 3, pp 342-344, issn 0033-3158Article
Effects of the D3 and autoreceptor-preferring dopamine antagonist (+)-UH232 in schizophreniaLAHTI, A. C; WEILER, M; CARLSSON, A et al.Journal of neural transmission. 1998, Vol 105, Num 6-7, pp 719-734, issn 0300-9564Article
Time to clozapine response in a standardized trialCONLEY, R. R; CARPENTER, W. T; TAMMINGA, C. A et al.The American journal of psychiatry. 1997, Vol 154, Num 9, pp 1243-1247, issn 0002-953XArticle
Recent developments in the neuropharmacology of schizophreniaLAHTI, A. C; TAMMINGA, C. A.American journal of health-system pharmacy. 1995, Vol 52, Num 3, pp S5-S8, issn 1079-2082, SUP1Conference Paper
Cerebrospinal fluid levels of quinolinic acid in Huntington's disease and schizophreniaSCHWARCZ, R; TAMMINGA, C. A; KURLAN, R et al.Annals of neurology. 1988, Vol 24, Num 4, pp 580-582, issn 0364-5134Article
Subanesthetic doses of ketamine stimulate psychosis in schizophreniaLAHTI, A. C; KOFFEL, B; LAPORTE, D et al.Neuropsychopharmacology (New York, NY). 1995, Vol 13, Num 1, pp 9-19, issn 0893-133XArticle
Delayed regional metabolic actions of phencyclidineXUE-MIN GAO; SHIRAKAWA, O; FU DU et al.European journal of pharmacology. 1993, Vol 241, Num 1, pp 7-15, issn 0014-2999Article
